PFE Dividend Calculator
Pfizer Inc. distributes every quarter. The field below opens with PFE's own recorded trailing payout of $1.7200 per share, as of 2026-08-18.
Enter the share price you are paying to see the projection. We publish no price data, so this is the one figure the page cannot fill in for you.
Payout figures read from Pfizer investor relations on Aug 18, 2026. You supply the share price. The PFE record page holds every payment behind these figures.
What the PFE Calculator Loads, and the Arithmetic Behind It
The 4 PFE payments with ex-dates between November 7, 2025 and August 18, 2026 add up to $1.7200 per share once split adjustment is applied. Worked on a round position, 1,000 shares collected 1,000 × $1.7200 = $1,720.00 across that window, which is $143.33 a month if you flatten it and $430.00 per payment on the 4-payment cadence. The calculator performs the same multiplication against whatever share count your investment and share price produce.
Those 4 payments span 284 days rather than a full 365, because our PFE record opens on November 9, 2023. The sum is a complete cadence year, meaning the full number of payments PFE's schedule implies, rather than a complete calendar one. Read it as slightly conservative for a full year, and re-check it once the record deepens.
Year one of the model is that same multiplication; each later year multiplies $1.7200 by one plus the growth rate you type. The methodology page states the rest.
What PFE's quarterly Cadence Does to the Model
PFE distributes every quarter, which is 4 payments a year. The projection above steps once a year, so a twenty-year run performs 20 reinvestments where PFE would have offered 80. Every payment between the annual steps is treated as though it arrived on the last day of the year. Observed gaps between PFE ex-dates ran 77 to 105 days, median 78.
Reinvesting each of those 4 payments as it landed, rather than once at the end of the year, earns more than the annual step shows, because earlier shares collect later payments. Holding the share price flat so timing is the only moving part, and computed from PFE's own payment weights, a 4% distribution rate gives 1.51% more first-year income, and a 20% distribution rate gives 7.75% more first-year income. The effect scales with the rate you are modelling, which is why it matters more for a high-distribution fund than for a slow grower, and it stays small next to the variability in the payout itself.
One term decides how far the annual step falls short, and for PFE it is 37.5%: a measure of how evenly the window's cash is split across its payments. A single lump scores zero, four equal payments 37.5%, twelve 45.8%, and fifty-two 49.0%. PFE sits below the even end, because its cash is concentrated into fewer or more unequal payments, and the annual step distorts less there than it would for a smooth stream.
Where PFE's Cash Actually Landed
The 9 complete calendar months ending Jul 2026, from PFE's recorded ex-dates, split-adjusted, as of 2026-08-18. Income is what 1,000 shares would have collected. A projection divides one annual figure by twelve; the record did this instead.
| Month | Payments | Per Share | On 1,000 Shares | Share of Window |
|---|---|---|---|---|
| Nov 2025 | 1 | $0.4300 | $430.00 | 25.0% |
| Dec 2025 | 0 | $0.0000 | $0.00 | 0.0% |
| Jan 2026 | 1 | $0.4300 | $430.00 | 25.0% |
| Feb 2026 | 0 | $0.0000 | $0.00 | 0.0% |
| Mar 2026 | 0 | $0.0000 | $0.00 | 0.0% |
| Apr 2026 | 0 | $0.0000 | $0.00 | 0.0% |
| May 2026 | 1 | $0.4300 | $430.00 | 25.0% |
| Jun 2026 | 0 | $0.0000 | $0.00 | 0.0% |
| Jul 2026 | 1 | $0.4300 | $430.00 | 25.0% |
| 9 months | 4 | $1.7200 | $1,720.00 | 100.0% |
Nov 2025 was the largest month at $0.4300 per share, carrying 25.0% of the 9-month total on its own. 5 of the 9 months paid nothing at all, which is what a quarterly or occasional schedule looks like once a monthly income plan is laid over it.
Shares and Capital for a Monthly Income Target from PFE
Share counts that would have produced each monthly target at PFE's recorded trailing payout of $1.7200 per share, as of 2026-08-18. This is division on a recorded figure, not advice, and the payout can move. We hold no price for PFE and publish none, so there is no capital column. Multiply the share count by the price you can actually buy at.
| Monthly Target | A Year | PFE Shares | Average per Payment |
|---|---|---|---|
| $200 | $2,400 | 1,396 | $600.28 |
| $750 | $9,000 | 5,233 | $2,250.19 |
| $2,000 | $24,000 | 13,954 | $6,000.22 |
| $5,000 | $60,000 | 34,884 | $15,000.12 |
Read the monthly column as an average rather than a schedule. On the record above, 5 of the last 9 months delivered nothing, so a holder of 13,954 shares aiming at $2,000 a month received it in 4 lumps instead. The record-side arithmetic, at different target levels, is on the PFE record page.
The Growth Input for PFE
PFE has a realised rate you can use instead of a guess: 2.4% a year, measured as the compound annual rate between PFE's split-adjusted 2024 payout of $1.6800 and its 2025 payout of $1.7200, which is 1 year of record. A realised rate is still an assumption about the future once you type it into a projection, but it is an assumption with a measurement behind it, which an invented 8% is not.
Per share, with no price assumption anywhere in it, this is what that rate does to PFE's payout against holding it flat. The cumulative column sums the payout from year one through the year shown.
| Year | Flat at $1.7200 | At 2.4% | Cumulative at 2.4% |
|---|---|---|---|
| Year 1 | $1.7200 | $1.7200 | $1.72 |
| Year 5 | $1.7200 | $1.8898 | $9.02 |
| Year 10 | $1.7200 | $2.1257 | $19.16 |
| Year 20 | $1.7200 | $2.6896 | $43.41 |
By year twenty the difference between 2.4% and zero is $0.9696 per share, which is 56% of the flat figure. That is the sensitivity of an entire projection to one field. Run it at the realised rate, run it again at zero, and treat the gap between the two answers as the honest result.
What Makes PFE Hard to Model
Each item is triggered by something computed from PFE's own record and carries the figure that triggered it.
5 of the last 9 months paid PFE holders nothing. The monthly income figure a projection implies is an annual total divided by twelve. On the record, PFE's cash arrived in 4 of 9 calendar months, with Nov 2025 the largest at $0.4300 per share. Anyone planning to spend the income needs the payment months, not the average, and the months are in the table above.
Starting a PFE Projection Today
A projection books a full year of income in year one. Today is August 21, 2026, 233 days into 2026. PFE has already gone ex-dividend 3 times in 2026, for $1.2900 per share, and buying now collects none of it. On the observed cadence, about 2 more payments would fall before 31 December, which is 50% of a normal year for PFE. That is a read of the record rather than a schedule PFE has published.
Nothing further is declared for PFE on our record, so every payment inside the projection is a modelled one. Based on the 78-day gap the record shows, the next ex-date would ordinarily land between Sep 30, 2026 and Oct 20, 2026, which is a pattern rather than an announcement. Read year one as twelve months from your purchase date, not the rest of this calendar year.
Frequently Asked Questions
What annual dividend figure should I use for PFE?
$1.7200 per share, the sum of the 4 split-adjusted PFE payments with ex-dates between November 7, 2025 and August 18, 2026, read from Pfizer investor relations: dividend and split history on 2026-08-18. It is already in the field. It records what was paid; it is not a rate the payer has committed to.
What growth rate should I put in the PFE calculator?
The rate PFE's own record realised is 2.4% a year, measured as the compound annual rate between PFE's split-adjusted 2024 payout of $1.6800 and its 2025 payout of $1.7200, which is 1 year of record. Using a realised rate beats inventing one, though it is still an assumption about the future rather than a property of it. Run the projection at that rate and again at zero, and read the gap as the answer.
How many PFE shares would pay $5,000 a month?
About 34,884 shares at the trailing payout of $1.7200 per share, which is $60,000 a year. Spread over 4 payments a year that averages $15,000.12 a payment, and the payments are not equal. What that costs depends on the price you pay, which we do not publish.
Are taxes included in the PFE projection?
No. Every figure the calculator produces is pre-tax and ignores trading costs. Pfizer Inc. is an operating company, so the tax character of its payments turns on holding periods and on the account you hold it in.
Why does the PFE calculator ask me for the share price?
Because we publish no prices. Every figure here carries the date its source was read, and a live quote cannot. Pfizer investor relations: dividend and split history publishes no distribution rate for PFE that we could turn into an implied price by arithmetic, so the price field starts empty.
Every payment, split adjustment, and calendar-year total behind these figures is on the PFE dividend history page. Other quarterly payers in coverage are on the coverage table. The general-purpose tools sit on the calculator hub, and the model is written out on the methodology page.